Article Details

Roche (RHHBY) Study Shows Lunsumio and Polivy Effectiveness in Lymphoma Treatment

Retrieved on: 2025-06-20 19:05:08

Tags for this article:

Click the tags to see associated articles and topics

Roche (RHHBY) Study Shows Lunsumio and Polivy Effectiveness in Lymphoma Treatment. View article details on hiswai:

Excerpt

Genentech's trial yields a 59% reduction in disease progression for lymphoma patients. · Analysts forecast a potential 14.78% upside for Roche (RHHBY, ...

Article found on: www.gurufocus.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo